{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T08:36:44Z","timestamp":1782549404751,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001203","name":"GlaxoSmithKline Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001203","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.cmi.2018.12.026","type":"journal-article","created":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T21:05:04Z","timestamp":1545858304000},"page":"1006-1012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Combination therapy with ciprofloxacin and third-generation cephalosporin versus third-generation cephalosporin monotherapy in Escherichia coli meningitis in infants: a multicentre propensity score\u2013matched observational study"],"prefix":"10.1016","volume":"25","author":[{"given":"M.","family":"Tauzin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Ouldali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"L\u00e9vy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"B\u00e9chet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Caeymaex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2018.12.026_bib1","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/cid\/civ367","article-title":"Escherichia coli meningitis features in 325 children from 2001 to 2013 in France","volume":"61","author":"Basmaci","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.12.026_bib2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/INF.0b013e3181fab1e7","article-title":"Neonatal bacterial meningitis: 444 cases in 7 years","volume":"30","author":"Gaschignard","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2018.12.026_bib3","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1093\/cid\/ciu514","article-title":"Incidence, etiology, and outcome of bacterial meningitis in infants aged <90 days in the United Kingdom and Republic of Ireland: prospective, enhanced, national population-based surveillance","volume":"59","author":"Okike","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.12.026_bib4","unstructured":"European Medicines Agency. Ciprofloxacin: summary of product characteristics. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/Ciprofloxacin_Bayer_30\/WC500008075.pdf."},{"key":"10.1016\/j.cmi.2018.12.026_bib5","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ijantimicag.2005.08.005","article-title":"Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children","volume":"26","author":"Goldwater","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2018.12.026_bib6","first-page":"1","article-title":"M\u00e9ningites n\u00e9onatales","volume":"11","author":"Aujard","year":"2016","journal-title":"EMC Pediatr"},{"key":"10.1016\/j.cmi.2018.12.026_bib7","first-page":"CD010435","article-title":"Adjuvant corticosteroids for reducing death in neonatal bacterial meningitis","author":"Ogunlesi","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2018.12.026_bib8","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1016\/S0929-693X(12)71288-5","article-title":"Therapeutic strategies for Escherichia coli neonatal meningitis","volume":"19","author":"Durrmeyer","year":"2012","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.cmi.2018.12.026_bib9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1473-3099(03)00736-9","article-title":"Fluoroquinolones in paediatrics: a risk for the patient or for the community?","volume":"3","author":"Gendrel","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2018.12.026_bib10","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S0929-693X(18)30041-1","article-title":"Antibioth\u00e9rapie des infections n\u00e9onatales bact\u00e9riennes pr\u00e9coces chez les nouveau-n\u00e9s n\u00e9s \u00e0 partir de 34 semaines d'am\u00e9norrh\u00e9e","volume":"24","author":"Romain","year":"2017","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.cmi.2018.12.026_bib11","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1086\/425368","article-title":"Practice guidelines for the management of bacterial meningitis","volume":"39","author":"Tunkel","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.12.026_bib12","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s004310050949","article-title":"Ciprofloxacin in preterm neonates: case report and review of the literature","volume":"157","author":"van den Oever","year":"1998","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.cmi.2018.12.026_bib13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0732-8893(99)00052-8","article-title":"Ciprofloxacin in treatment of nosocomial meningitis in neonates and in infants: report of 12 cases and review","volume":"35","author":"Krcm\u00e9ry","year":"1999","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2018.12.026_bib14","first-page":"253","article-title":"The treatment of neonatal meningitis due to Gram-negative bacilli with ciprofloxacin: evidence of satisfactory penetration into the cerebrospinal fluid","volume":"26","author":"Green","year":"1993","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2018.12.026_bib15","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1128\/AAC.35.11.2215","article-title":"In\u00a0vitro and in\u00a0vivo ciprofloxacin pharmacokinetics in human neutrophils","volume":"35","author":"Garraffo","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.12.026_bib16","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/BF01963940","article-title":"Penetration of ciprofloxacin into human cerebrospinal fluid in patients with inflamed and non-inflamed meninges","volume":"10","author":"Gogos","year":"1991","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2018.12.026_bib17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ana.22190","article-title":"Ciprofloxacin prevents myelination delay in neonatal rats subjected to E.\u00a0coli sepsis","volume":"69","author":"Loron","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cmi.2018.12.026_bib18","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/adc.2010.208843","article-title":"Ciprofloxacin safety in paediatrics: a systematic review","volume":"96","author":"Adefurin","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.cmi.2018.12.026_bib19","first-page":"16","article-title":"Evaluation of the surveillance of paediatric pneumococcal meningitis infections in France, 2001\u20132002 by capture\u2013recapture method","volume":"3","author":"Perrocheau","year":"2006","journal-title":"Null Epidemiol Hebd"},{"key":"10.1016\/j.cmi.2018.12.026_bib20","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1093\/eurheartj\/ehs186","article-title":"Comparing treatment effects between propensity scores and randomized controlled trials: improving conduct and reporting","volume":"33","author":"Collins","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cmi.2018.12.026_bib21","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/aje\/kwu469","article-title":"Propensity score methods for analyzing observational data like randomized experiments: challenges and solutions for rare outcomes and exposures","volume":"181","author":"Ross","year":"2015","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cmi.2018.12.026_bib22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2217\/cer-2017-0071","article-title":"Handling missing data in propensity score estimation in comparative effectiveness evaluations: a systematic review","volume":"7","author":"Malla","year":"2018","journal-title":"J\u00a0Comp Eff Res"},{"key":"10.1016\/j.cmi.2018.12.026_bib23","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/0962280212445945","article-title":"A\u00a0comparison of two methods of estimating propensity scores after multiple imputation","volume":"25","author":"Mitra","year":"2016","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.cmi.2018.12.026_bib24","series-title":"Journ\u00e9es parisiennes de p\u00e9diatrie","first-page":"15","article-title":"M\u00e9ningites n\u00e9onatales: place des fluoroquinolones","author":"Le Huidoux","year":"1999"},{"key":"10.1016\/j.cmi.2018.12.026_bib25","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/jac\/17.4.535","article-title":"Successful treatment of Pseudomonas ventriculitis with ciprofloxacin","volume":"17","author":"Isaacs","year":"1986","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.12.026_bib26","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/00006454-199308000-00010","article-title":"Multiple brain abscesses caused by Salmonella enteritidis in a neonate: successful treatment with ciprofloxacin","volume":"12","author":"Wessalowski","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2018.12.026_bib27","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1056\/NEJMoa010399","article-title":"Computed tomography of the head before lumbar puncture in adults with suspected meningitis","volume":"345","author":"Hasbun","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2018.12.026_bib28","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3109\/15376516.2015.1026008","article-title":"Ciprofloxacin-induced neurotoxicity: evaluation of possible underlying mechanisms","volume":"25","author":"Ilgin","year":"2015","journal-title":"Toxicol Mech Methods"},{"key":"10.1016\/j.cmi.2018.12.026_bib29","doi-asserted-by":"crossref","first-page":"e1148","DOI":"10.1542\/peds.2013-3363","article-title":"Empiric combination therapy for Gram-negative bacteremia","volume":"133","author":"Sick","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.cmi.2018.12.026_bib30","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/INF.0000000000000885","article-title":"Empiric monotherapy versus combination therapy for Enterobacteriaceae bacteremia in children","volume":"34","author":"Berkowitz","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2018.12.026_bib31","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/jamapediatrics.2013.196","article-title":"Less is more: combination antibiotic therapy for the treatment of Gram-negative bacteremia in pediatric patients","volume":"167","author":"Tamma","year":"2013","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.cmi.2018.12.026_bib32","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(04)01108-9","article-title":"Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis","volume":"4","author":"Safdar","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2018.12.026_bib33","first-page":"CD003344","article-title":"Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis","volume":"1","author":"Paul","year":"2014","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X18308164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X18308164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:23:05Z","timestamp":1761117785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X18308164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1198743X18308164"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2018.12.026","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination therapy with ciprofloxacin and third-generation cephalosporin versus third-generation cephalosporin monotherapy in Escherichia coli meningitis in infants: a multicentre propensity score\u2013matched observational study","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2018.12.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}